TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28093573

Group type: EXPERIMENTAL
Intervention: Dietary advices and physical activity assessed by pedometer (PA+D)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Physical activity assessed by pedometer (PA)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Non-compliant women (less than 11,000 steps per day)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: High carbohydrate intake
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Intervention and control groups
Number of subjects: 425
Study: 26316264

Group type: COMPARATOR
Intervention: Standard-of-care transplant education provided by the dialysis center
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Patient-guided ETH (ETH-PG)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Health educator-guided ETH (ETH-EG)
Number of subjects: 540
Study: 22448901

Group type: EXPERIMENTAL
Intervention: Anodal TDCS (2mA for 20min, 5 daily sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham TDCS
Number of subjects: 50
Study: 21354343

Group type: COMPARATOR
Intervention: Excision with primary repair
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Limberg flap
Number of subjects: 100
Study: 18079286

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI, 20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg) as rescue medication
Number of subjects: 100
Study: 17313004

Group type: EXPERIMENTAL
Intervention: Acupuncture at Zusanli (ST 36) and Xuanzhong (GB 39)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Routine treatment for ischemic stroke (Control group)
Number of subjects: 160
Study: 12750656

Group type: EXPERIMENTAL
Intervention: 24-Hour Schedule (24HS) questionnaire and assessment by trained examiners
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Assessment of back posture (flexed vs. lordotic)
Number of subjects: 40
Study: 10972330

Group type: EXPERIMENTAL
Intervention: Allogeneic dendritic cells pulsed with HIV MN gp160 protein or peptides from HLA-A2 restricted epitopes of env, gag, and pol proteins, infused every month for 6-9 months.
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Allogeneic dendritic cells infusion
Number of subjects: 5
Study: 9168216

Group type: EXPERIMENTAL
Intervention: Tramadol and beta-cyclodextrin piroxicam (BCPT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Beta-cyclodextrin piroxicam (BCP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (placebo tablet and saline infusion)
Number of subjects: 48
Study: 1556523

Group type: EXPERIMENTAL
Intervention: 3 g Na2EDTA
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 3893599

Group type: EXPERIMENTAL
Intervention: Depot neuroleptics
Number of subjects: 73
Study: 31087451

Group type: EXPERIMENTAL
Intervention: Immediate ANAIS (intervention group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Delayed ANAIS (control group)
Number of subjects: 80
Study: 30197148

Group type: EXPERIMENTAL
Intervention: Kleb‐SRP vaccine administered before calving
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Kleb‐SRP vaccine administered after calving
Number of subjects: 569

Group type: COMPARATOR
Intervention: Placebo formulation
Number of subjects: 569
Study: 26865592

Group type: COMPARATOR
Intervention: Sf2aWC vaccine (formalin‐inactivated whole‐cell Shigella flexneri 2a), given orally in three doses (2.6 ± 0.8 × 10(8), × 10(9), × 10(10), and × 10(11)vaccine particles/ml)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sf2aWC vaccine
Number of subjects: 82
Study: 24488983

Group type: EXPERIMENTAL
Intervention: Inotropic therapy (dobutamine 43%, dopamine 24%, milrinone 17%, combination 16%)
Number of subjects: 126564

Group type: EXPERIMENTAL
Intervention: Higher risk-standardized inotrope use
Number of subjects: 126564
Study: 22747904

Group type: EXPERIMENTAL
Intervention: Educational intervention (IG)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 192
Study: 21319614

Group type: EXPERIMENTAL
Intervention: Advance cue provided to the kicker
Number of subjects: 32

Group type: COMPARATOR
Intervention: No advance cue (Control group)
Number of subjects: 32
Study: 17441415

Group type: EXPERIMENTAL
Intervention: GliSODin (vegetal SOD with gliadin)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 76
Study: 16255189

Group type: EXPERIMENTAL
Intervention: Intravenous injection of Zinacef
Number of subjects: 0
Study: 12523682

Group type: EXPERIMENTAL
Intervention: Carvedilol (n = 10)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Atenolol (n = 10)
Number of subjects: 250
Study: 10334653

Group type: EXPERIMENTAL
Intervention: Yoghurt enriched with Lactobacillus acidophilus L‐1
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control yoghurt
Number of subjects: 78
Study: 8532943

Group type: EXPERIMENTAL
Intervention: Gallopamil
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1904120

Group type: EXPERIMENTAL
Intervention: Maintenance group received six weekly instillations of 80 mg of BCG and four additional instillations every three months.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-maintenance group received six weekly instillations of 80 mg of BCG.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Patients with pT1b tumor in maintenance group.
Number of subjects: 42
Study: 31822157

Group type: EXPERIMENTAL
Intervention: Butylphthalide injection
Number of subjects: 98

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 98
Study: 30477629

Group type: EXPERIMENTAL
Intervention: PND 0.5 group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PND 7 group
Number of subjects: 24
Study: 27788931

Group type: EXPERIMENTAL
Intervention: Bare-metal stents
Number of subjects: 283

Group type: COMPARATOR
Intervention: Drug-eluting stents (DES)
Number of subjects: 283
Study: 26265520

Group type: EXPERIMENTAL
Intervention: PolyPill (daily single dose consisting of aspirin, valsartan, atorvastatin, and hydrochlorthiazide)
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2400
Study: 23766359

Group type: EXPERIMENTAL
Intervention: Vandetanib 100 mg/m(2) administered orally, once daily, continuously for 28-day treatment cycles (with possible escalation to 150 mg/m(2)/d after two cycles).
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vandetanib treatment.
Number of subjects: 16
Study: 21424043

Group type: EXPERIMENTAL
Intervention: Photodynamic diagnosis (PDD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional methods (WLC)
Number of subjects: 44
Study: 18415952

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 648

Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 648
Study: 16596105

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation (0.3 g/kg body mass/day for 5 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate supplementation
Number of subjects: 17
Study: 12384627

Group type: EXPERIMENTAL
Intervention: NIR stent implantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gold-plated NIR stent
Number of subjects: 0
Study: 9665902

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy
Number of subjects: 3744

Group type: COMPARATOR
Intervention: Faecal occult blood testing
Number of subjects: 3744

Group type: COMPARATOR
Intervention: Both tests combined
Number of subjects: 3744
Study: 7930281

Group type: EXPERIMENTAL
Intervention: Obesity (measured by body mass index)
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Black race
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: Left ventricular hypertrophy
Number of subjects: 692
Study: 2502955

Group type: EXPERIMENTAL
Intervention: Rioprostil 300 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rioprostil 600 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1219183

Group type: EXPERIMENTAL
Intervention: Intravenous administration of synthetic secretin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pernasal administration of synthetic secretin (snuff)
Number of subjects: 10
Study: 7399873

Group type: EXPERIMENTAL
Intervention: Oxprenolol and diuretics for the first eight weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo plus diuretics for the second eight weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Diuretics for the first eight weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Diuretics for the second eight weeks
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Oxprenolol and diuretics in reverse order for Group 2
Number of subjects: 66
Study: 30545780

Group type: EXPERIMENTAL
Intervention: Oral ixazomib (3 mg initially, increased to 4 mg from cycle 5 if tolerated)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Oral ixazomib
Number of subjects: 656
Study: 29607860

Group type: EXPERIMENTAL
Intervention: Buccal infiltration anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inferior alveolar nerve block (IANB)
Number of subjects: 40
Study: 26219614

Group type: EXPERIMENTAL
Intervention: Ketamine (1.5 μg kg min(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Ketamine and Saline)
Number of subjects: 20
Study: 24439245

Group type: EXPERIMENTAL
Intervention: Axillary nerve block (Ax group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Portal site injections of local anesthetic (Lo group)
Number of subjects: 36
Study: 22687265

Group type: EXPERIMENTAL
Intervention: Guided self-help cognitive behavioural therapy (CBT) for four weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 70
Study: 19604351

Group type: EXPERIMENTAL
Intervention: Self administered version of the 'Business in Mind' program
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Telephone facilitated version of the 'Business in Mind' program
Number of subjects: 249

Group type: COMPARATOR
Intervention: Active control condition (psychoeducation only)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Subordinate perceptions of manager support
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Absenteeism and presenteeism rates
Number of subjects: 249
Study: 17587301

Group type: EXPERIMENTAL
Intervention: 1-month reference period (RP-1)
Number of subjects: 215

Group type: COMPARATOR
Intervention: 12-month reference period (RP-12)
Number of subjects: 215
Study: 15167957

Group type: EXPERIMENTAL
Intervention: Patients with ToF and non-sustained VT
Number of subjects: 23

Group type: COMPARATOR
Intervention: Patients with ToF (all)
Number of subjects: 23
Study: 12195171

Group type: EXPERIMENTAL
Intervention: Wide Dynamic Range Compressor (WDRC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Linear Peak Clipper
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Compression Limiter
Number of subjects: 360

Group type: COMPARATOR
Intervention: All circuits
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Linear Compression-Limited Circuit
Number of subjects: 360
Study: 9539490

Group type: EXPERIMENTAL
Intervention: Gradually increased slow balloon inflation
Number of subjects: 207

Group type: COMPARATOR
Intervention: Fast balloon inflation
Number of subjects: 207
Study: 7635601

Group type: EXPERIMENTAL
Intervention: 7-day diet recalls (7DDR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 24-hour diet recalls (24HR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social desirability score
Number of subjects: 0
Study: 2297191

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPSS)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 379931

Group type: EXPERIMENTAL
Intervention: Conventional treatment complemented by injections of poly A‐poly U
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both therapeutic groups
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Conventional treatment and poly A‐poly U
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Radiotherapy in patients with lymph node involvement
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Patients with SS factor
Number of subjects: 159
Study: 30640238

Group type: EXPERIMENTAL
Intervention: Cash-based physical therapy
Number of subjects: 48
Study: 28654954

Group type: EXPERIMENTAL
Intervention: Branded lamotrigine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Generic lamotrigine 1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Generic lamotrigine 2
Number of subjects: 50

Group type: COMPARATOR
Intervention: All three products
Number of subjects: 50
Study: 25978169

Group type: EXPERIMENTAL
Intervention: SRT2104 (2 g/d for 7 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SRT2104 (single dose of 2 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SRT2104 (both single and repeated administration)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SRT2104
Number of subjects: 24
Study: 23359358

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (68% vertical-banded gastroplasty, 19% banding, and 13% gastric bypass)
Number of subjects: 4047

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 4047
Study: 21245461

Group type: EXPERIMENTAL
Intervention: Targeted performance feedback (supplemental report on the 'top 3' hospital-specific performance gaps)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Standard performance feedback reports
Number of subjects: 149
Study: 19526798

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) group (group A) - one dose of TCM every day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Western medicine group (group B) - subcutaneous injection of low‐molecular‐weight heparins calcium (LMWH)
Number of subjects: 70
Study: 17722820

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Zhigou (TE 6) for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electroacupuncture at non-acupoint for 4 weeks (Control)
Number of subjects: 0
Study: 15033608

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitor therapy (ACEI)
Number of subjects: 20
Study: 11597289

Group type: EXPERIMENTAL
Intervention: Intravenous antithrombin III (30,000 IU in total over 4 days)
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Placebo (1% human albumin)
Number of subjects: 2314

Group type: EXPERIMENTAL
Intervention: Intravenous antithrombin III (30,000 IU in total over 4 days) with concomitant heparin
Number of subjects: 2314

Group type: COMPARATOR
Intervention: Placebo (1% human albumin) with concomitant heparin
Number of subjects: 2314
Study: 9874886

Group type: EXPERIMENTAL
Intervention: Oral PowderJect (OPJ) with powdered lidocaine hydrochloride
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham OPJ (empty)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control site (untreated)
Number of subjects: 14
Study: 8033368

Group type: EXPERIMENTAL
Intervention: Glucocorticoid withdrawal
Number of subjects: 9
Study: 2917116

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: No H2-blocker
Number of subjects: 30
Study: 803184

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methylphenidate vs Caffeine
Number of subjects: 8
Study: 31910748

Group type: EXPERIMENTAL
Intervention: Hypothyroidism
Number of subjects: 480698

Group type: EXPERIMENTAL
Intervention: Increased TSH
Number of subjects: 480698

Group type: EXPERIMENTAL
Intervention: TPOAb
Number of subjects: 480698
Study: 30431563

Group type: EXPERIMENTAL
Intervention: Comprehensive preoperative regimen (SDD, probiotics, and smectite)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 28345387

Group type: EXPERIMENTAL
Intervention: Multimodal treatment (NF + MED)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: MED alone
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: NF alone
Number of subjects: 130
Study: 26244887

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combined interventions (increasing FIO2 to 1.0 and increasing PETCO2 to 45 mmHg)
Number of subjects: 56
Study: 24102295

Group type: EXPERIMENTAL
Intervention: Gaming console exercise in addition to usual therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Usual therapy alone
Number of subjects: 21
Study: 20935613

Group type: EXPERIMENTAL
Intervention: Propofol TCI (group P)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Sevoflurane (group S)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study: 18583331

Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS) using FISH analysis for chromosomes X, Y, 13, 16, 18, 21, and 22
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no PGS)
Number of subjects: 109
Study: 15877932

Group type: EXPERIMENTAL
Intervention: scopolamine (0.4 mg i.m.)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: mecamylamine (15 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: mecamylamine (15 mg)/scopolamine (0.4 mg i.m.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 12946658

Group type: EXPERIMENTAL
Intervention: Insomniacs (n = 17)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Depressed patients (n = 14)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control subjects (n = 31)
Number of subjects: 62
Study: 10389124

Group type: EXPERIMENTAL
Intervention: Eperisone hydrochloride (50 mg t.i.d.)
Number of subjects: 157
Study: 8735069

Group type: EXPERIMENTAL
Intervention: Physical exercise at 60% of VO2max for 10 minutes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Noise exposure (third-octave band noise of 102 dB SPL centered at 2 kHz) for 10 minutes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combination of noise exposure and exercise for 10 minutes
Number of subjects: 8

Group type: COMPARATOR
Intervention: Physical exercise without noise exposure
Number of subjects: 8
Study: 1868681

Group type: EXPERIMENTAL
Intervention: Cefuroxime prophylaxis (one or three doses)
Number of subjects: 3023
Study: 6809475

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg p.o.)
Number of subjects: 6
Study: 30793412

Group type: EXPERIMENTAL
Intervention: Complete stop of acute medication (programme A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Restricted intake of acute medication (programme B)
Number of subjects: 72
Study: 30254745

Group type: EXPERIMENTAL
Intervention: Longitudinal phone group
Number of subjects: 749

Group type: COMPARATOR
Intervention: Longitudinal control group
Number of subjects: 749

Group type: COMPARATOR
Intervention: Cross-sectional control group
Number of subjects: 749
Study: 28017399

Group type: EXPERIMENTAL
Intervention: High-dose vaccine (1.6 × 10^11 viral particles)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine (8.0 × 10^10 viral particles)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo (containing only vaccine excipients)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: High-dose vaccine
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 25827693

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting (OPCAB)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: On-pump beating heart (OnP-BH)
Number of subjects: 668

Group type: EXPERIMENTAL
Intervention: Conventional on-pump CABG (OnP)
Number of subjects: 668
Study: 23237314

Group type: EXPERIMENTAL
Intervention: Nalmefene 18 mg
Number of subjects: 604

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 604
Study: 20672723

Group type: EXPERIMENTAL
Intervention: Grandio (nanohybrid composite)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Quixfil (low shrinkage posterior composite)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both Grandio and Quixfil
Number of subjects: 31
Study: 18385328

Group type: EXPERIMENTAL
Intervention: Amino acid mixture deficient in dopamine precursors (tyrosine and phenylalanine)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Nutritionally balanced mixture
Number of subjects: 19
Study: 16792582

Group type: EXPERIMENTAL
Intervention: Subcutaneous SQ-standardized specific immunotherapy (SIT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 54
Study: 12862247

Group type: EXPERIMENTAL
Intervention: Non-vegetarian group
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Vegetarian group
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus patients
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Cardiovascular disorders patients
Number of subjects: 408

Group type: COMPARATOR
Intervention: General population
Number of subjects: 408
Study: 11026947

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Befriending
Number of subjects: 0
Study: 8797032

Group type: EXPERIMENTAL
Intervention: Treadmill exercise test in athletes
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Treadmill exercise test in non-athletes
Number of subjects: 31